scholarly journals Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans

2018 ◽  
Author(s):  
Pramila Rijal ◽  
Sean C. Elias ◽  
Samara Rosendo Machado ◽  
Julie Xiao ◽  
Lisa Schimanski ◽  
...  
Cell Reports ◽  
2019 ◽  
Vol 27 (1) ◽  
pp. 172-186.e7 ◽  
Author(s):  
Pramila Rijal ◽  
Sean C. Elias ◽  
Samara Rosendo Machado ◽  
Julie Xiao ◽  
Lisa Schimanski ◽  
...  

2012 ◽  
Vol 6 (3) ◽  
pp. e1575 ◽  
Author(s):  
Xiangguo Qiu ◽  
Lisa Fernando ◽  
P. Leno Melito ◽  
Jonathan Audet ◽  
Heinz Feldmann ◽  
...  

2018 ◽  
Vol 217 (6) ◽  
pp. 916-925 ◽  
Author(s):  
Laura P van Lieshout ◽  
Geoff Soule ◽  
Debra Sorensen ◽  
Kathy L Frost ◽  
Shihua He ◽  
...  

2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Qi Zhang ◽  
Miao Gui ◽  
Xuefeng Niu ◽  
Shihua He ◽  
Ruoke Wang ◽  
...  

2003 ◽  
Vol 77 (13) ◽  
pp. 7539-7544 ◽  
Author(s):  
Ayato Takada ◽  
Heinz Feldmann ◽  
Thomas G. Ksiazek ◽  
Yoshihiro Kawaoka

ABSTRACT Most strains of Ebola virus cause a rapidly fatal hemorrhagic disease in humans, yet there are still no biologic explanations that adequately account for the extreme virulence of these emerging pathogens. Here we show that Ebola Zaire virus infection in humans induces antibodies that enhance viral infectivity. Plasma or serum from convalescing patients enhanced the infection of primate kidney cells by the Zaire virus, and this enhancement was mediated by antibodies to the viral glycoprotein and by complement component C1q. Our results suggest a novel mechanism of antibody-dependent enhancement of Ebola virus infection, one that would account for the dire outcome of Ebola outbreaks in human populations.


Sign in / Sign up

Export Citation Format

Share Document